Review identifies Nogo-A's role in neuroplasticity and disease intervention, suggesting new treatment strategies.
The membrane protein Nogo-A, initially identified for its inhibitory role in axonal regeneration through the Nogo receptor (NgR), is now recognized as a central hub in a complex noncanonical signaling network. Recent evidence indicates that Nogo-A engages diverse receptors and intracellular pathways beyond NgR to modulate neuroplasticity, synaptic stability, and glial function. This multi-target regulatory capacity characterizes Nogo-A as a critical determinant of neural repair and degeneration, with implications for conditions such as spinal cord injury, multiple sclerosis, and Alzheimer’s disease. Noncanonical Nogo-A signaling intersects with growth factor cascades, inflammatory responses, and cytoskeletal dynamics, offering novel therapeutic targets for neural repair. This review synthesizes current knowledge on alternative Nogo-A signaling mechanisms and highlights their potential to redefine strategies for neuroregeneration and disease intervention. Graphical Abstract Noncanonical Nogo-A Signaling Network. This graphical abstract summarizes the Nogo-A signaling network. It illustrates how Nogo-A engages diverse receptors (e.g., PirB, S1PR2) beyond the classical NgR to activate divergent pathways, modulating neuroplasticity and offering novel therapeutic targets for neural repair
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: